GlassScriptPhysician profile
Lynn M Allison
NPI 1588091607
$11,719.78
in general payments reported to CMS, 2019-2025
55 companies · $3,000 in 2025
The $3,000 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,988 · 2022: $2,626 · 2023: $2,179 · 2024: $1,927 · 2025: $3,000.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,095 · Education: $11.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,094.76 |
| Education | $11.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,447.47 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $1,123.26 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,015.21 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Pfizer INC. | $783.24 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $766.01 | 2021-2025 | |
| Corcept Therapeutics | $650.00 | 2022-2025 | Korlym |
| Lilly USA, LLC | $593.26 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $567.84 | 2021-2025 | Repatha, Otezla, Evenity |
| Novartis Pharmaceuticals Corporation | $397.36 | 2021-2025 | |
| Glaxosmithkline, LLC. | $296.07 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Boston Scientific Corporation | $249.35 | 2023-2025 | Bodyguardian, Wavewriter Alpha Prime 16, Innova Vascular |
| Astellas Pharma US INC | $240.73 | 2021-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $206.17 | 2023-2025 | Gemtesa |
| Optinose US, INC. | $199.31 | 2021-2024 | |
| Lundbeck LLC | $189.70 | 2022-2025 | Rexulti |
Show all 55 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lynn Allison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.